Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douwe Postmus

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Patient Preference and Adherence|January 30, 2025
Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of ChoosingSonia Roldan Munoz, Peter G M Mol, Femke de Vries, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 7, 2011
Incidence of impaired renal function after lung transplantationMerel E Hellemons, Stephan J L Bakker, Douwe Postmus, et al.
Lung Cancer (Amsterdam, Netherlands)|December 21, 2024
CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysisErick Suazo-Zepeda, Alain R Viddeleer, Willemijn J Maas, et al.
The European Respiratory Journal|November 27, 2020
Using joint modelling to assess the association between a time-varying biomarker and a survival outcome: an illustrative example in respiratory medicineYuntao Chen, Douwe Postmus, Martin R Cowie, et al.
International Journal of Technology Assessment in Health Care|March 23, 2016
THE EARLY BIRD CATCHES THE WORM: EARLY COST-EFFECTIVENESS ANALYSIS OF NEW MEDICAL TESTSLeander R Buisman, Maureen P M H Rutten-van Mölken, Douwe Postmus, et al.
BMC Medicine|January 27, 2021
A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohortsYuntao Chen, Adriaan A Voors, Tiny Jaarsma, et al.
European Journal of Epidemiology|November 8, 2014
Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohortBiniyam G Demissei, Douwe Postmus, Mattia A Valente, et al.
BMC Infectious Diseases|December 18, 2020
Derivation and validation of a prognostic model for predicting in-hospital mortality in patients admitted with COVID-19 in Wuhan, China: the PLANS (platelet lymphocyte age neutrophil sex) modelJiong Li, Yuntao Chen, Shujing Chen, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Cardiac output drop reflects circulatory attrition after Fontan completion: serial cardiac magnetic resonance studySara C Arrigoni, Rolf M F Berger, Tjark Ebels, et al.
The Oncologist|October 29, 2017
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple MyelomaDouwe Postmus, Sarah Richard, Nathalie Bere, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Patient Preference and Adherence|January 30, 2025
Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of ChoosingSonia Roldan Munoz, Peter G M Mol, Femke de Vries, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 7, 2011
Incidence of impaired renal function after lung transplantationMerel E Hellemons, Stephan J L Bakker, Douwe Postmus, et al.
Lung Cancer (Amsterdam, Netherlands)|December 21, 2024
CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysisErick Suazo-Zepeda, Alain R Viddeleer, Willemijn J Maas, et al.
The European Respiratory Journal|November 27, 2020
Using joint modelling to assess the association between a time-varying biomarker and a survival outcome: an illustrative example in respiratory medicineYuntao Chen, Douwe Postmus, Martin R Cowie, et al.
International Journal of Technology Assessment in Health Care|March 23, 2016
THE EARLY BIRD CATCHES THE WORM: EARLY COST-EFFECTIVENESS ANALYSIS OF NEW MEDICAL TESTSLeander R Buisman, Maureen P M H Rutten-van Mölken, Douwe Postmus, et al.
BMC Medicine|January 27, 2021
A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohortsYuntao Chen, Adriaan A Voors, Tiny Jaarsma, et al.
European Journal of Epidemiology|November 8, 2014
Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohortBiniyam G Demissei, Douwe Postmus, Mattia A Valente, et al.
BMC Infectious Diseases|December 18, 2020
Derivation and validation of a prognostic model for predicting in-hospital mortality in patients admitted with COVID-19 in Wuhan, China: the PLANS (platelet lymphocyte age neutrophil sex) modelJiong Li, Yuntao Chen, Shujing Chen, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Cardiac output drop reflects circulatory attrition after Fontan completion: serial cardiac magnetic resonance studySara C Arrigoni, Rolf M F Berger, Tjark Ebels, et al.
The Oncologist|October 29, 2017
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple MyelomaDouwe Postmus, Sarah Richard, Nathalie Bere, et al.
Pageof 8